Z-Arg-Arg-Pro-Phe-His-Sta-Ile-His-Lys(Boc)-OMe
Modify Date: 2024-01-05 17:53:27
Z-Arg-Arg-Pro-Phe-His-Sta-Ile-His-Lys(Boc)-OMe structure
|
Common Name | Z-Arg-Arg-Pro-Phe-His-Sta-Ile-His-Lys(Boc)-OMe | ||
|---|---|---|---|---|
| CAS Number | 93287-54-8 | Molecular Weight | 1495.769 | |
| Density | 1.4±0.1 g/cm3 | Boiling Point | N/A | |
| Molecular Formula | C72H110N20O15 | Melting Point | N/A | |
| MSDS | Chinese USA | Flash Point | N/A | |
| Name | Z-Arg-Arg-Pro-Phe-His-Sta-Ile-His-Lys(Boc)-OMe |
|---|---|
| Synonym | More Synonyms |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Molecular Formula | C72H110N20O15 |
| Molecular Weight | 1495.769 |
| Exact Mass | 1494.845947 |
| LogP | 2.52 |
| Index of Refraction | 1.636 |
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| RIDADR | NONH for all modes of transport |
|
Sustained reduction in blood pressure during chronic administration of a renin inhibitor to normotensive marmosets.
J. Cardiovasc. Pharmacol. 10 Suppl 7 , S96-8, (1987) In this study, the hypotensive efficacy of a renin inhibitor was investigated during chronic administration. The renin inhibitor CGP 29,287 was administered by continuous intraperitoneal infusion with... |
|
|
Biochemical effects of prolonged renin inhibition in marmosets.
J. Hypertens. 7(8) , 615-8, (1989) The renin inhibitor CGP 29,287 was administered continuously for 7 days (30 mg/kg per day, intraperitoneally, via osmotic minipumps) to normotensive marmosets fed a low-salt diet. As a control, anothe... |
|
|
Comparison of chronic inhibition of renin and converting enzyme in the marmoset.
Clin. Exp. Hypertens. A. 9(2-3) , 337-43, (1987) The primate-specific renin inhibitor CGP 29287 (30 mg/kg/d, n = 5) or the converting-enzyme inhibitor CGS 14831 (30 mg/kg/d, n = 8) were administered by continuous intraperitoneal infusion via osmotic... |
| L-Histidinamide, N-[(phenylmethoxy)carbonyl]-L-arginyl-L-arginyl-L-prolyl-L-phenylalanyl-N-[(1S,2S,6S,9S,12S)-2-hydroxy-9-(1H-imidazol-4-ylmethyl)-12-(methoxycarbonyl)-20,20-dimethyl-6-[(1S)-1-meth ylpropyl]-1-(2-methylpropyl)-4,7,10,18-tetraoxo-19-oxa-5,8,11,17-tetraazaheneicos-1-yl]- |
| N-[(Benzyloxy)carbonyl]-L-arginyl-L-arginyl-L-prolyl-L-phenylalanyl-N-[(10S,13S,16S,20S,21S)-16-[(2S)-2-butanyl]-20-hydroxy-13-(1H-imidazol-4-ylmethyl)-10-(methoxycarbonyl)-2,2,23-trimethyl-4,12,15 ,18-tetraoxo-3-oxa-5,11,14,17-tetraazatetracosan-21-yl]-L-histidinamide |
| MFCD00133577 |